# Trending Content OS — Daily Run
**Run date:** 2026-09-04

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_news, serpapi_trends, google_news_radar]
  inactive_tools: [reddit_live, social_search, content_database]
  can_run_signal_listener: true
  notes: >
    site_url not configured — self-check skipped; competitor list (competitor_list.yaml)
    used for SERP-gap context instead. No data/deferred_topics.yaml entries had a
    recheck_on date due today. Run history shows "FDA recall surge" as a recurring
    theme across 5+ consecutive runs (08-28 → 09-03) — flagged for staleness; today's
    run only advances candidates tied to genuinely new products/pathogens within that
    cluster (epinephrine, sprouts), not repeats of already-covered recalls.
```

---

## 2. Google News Radar Coverage Summary

144 unique headlines reviewed across 12 queries. Main clusters:

| Cluster | Disposition |
|---|---|
| **FDA recalls & food safety** (sprouts outbreak, epinephrine, Medtronic, tofu, rice, guacamole, Baxter IV fluids, "summer of recalls" pieces) | **Retained (2 new):** epinephrine injection recall, sprouts E. coli/Salmonella outbreak. **Rejected — existing:** Medtronic, tofu, rice, guacamole, Baxter (all covered 08-28 → 09-03). |
| **Clinical trials & medical research** (Penn proton therapy, UAMS spinal-cord trial, ibogaine, GLP-1 psychiatric study, LGBTQ healthcare study, Stanford gene tool, Brown aging alliance, Drexel study) | **Monitored (P5):** Penn proton therapy trial (institutional-only sourcing, below trend threshold). **Rejected — existing:** ibogaine trial, GLP-1 psychiatric harm study, LGBTQ healthcare-access study. **Rejected — weak/niche:** UAMS, Drexel, Brown funding news (single-institution, thin national relevance). |
| **Clinical trial access & equity** (US News opinion, Penn LDI incentive study, NIH/Penn State rural grant, WHO Singapore centre) | **Rejected — existing/duplicate** of "cancer patients can't access trials" (covered 09-02) or too institutional/local. |
| **Corporate wellness & health-system business** (Sanford/North Memorial merger, ECU nurse awards, Luminis cyberattack, CVS/LOVB partnership, employer health-cost spike, wellness-incentive law changes) | **Rejected — off-category:** pure business/insurance/local-institution news, no clinical health angle. |
| **AI + healthcare** (OpenAI EHR integration, Axios "AI giants lean into health care") | **Rejected — off-category:** tech/business framing, no health-evidence angle. |
| **Screwworm/USDA livestock** | **Rejected — edge/low audience relevance:** agricultural/veterinary, no established human-health angle. |
| **Wellness stacking / suicide-prevention-month reiterations** | **Rejected — existing**, same themes covered 08-29 and 09-01 with no new development. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-04T13:00:00Z"
  run_completed_at: "2026-09-04T13:40:00Z"
  total_signals_reviewed: 158
  total_signals_retained: 3
  total_rejected: 155
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 38
    brand_safety: 0
    duplicate: 71
    weak_signal: 34
    unverified_claim: 0
    other: 12
  highest_priority_topic: "FDA epinephrine injection recall"
  strongest_signal_source: "FDA.gov outbreak investigation page (sprouts)"
  tools_unavailable: [reddit_live, social_search, content_database]
  notes: >
    Google Trends confirmed strong rising interest in "gut health"/magnesium queries and
    general "health"/"mental health" categories, but news-led signals dominated retained
    candidates. FDA recall cluster remains the dominant news driver for the 6th
    consecutive day — genuinely new items (epinephrine, sprouts) were separated from
    repeat coverage of previously-reported recalls.
```

---

## 4. Skill 02b Routing Summary

| Topic | Risk Type | Primary Source | Claim Alignment | Gate Result |
|---|---|---|---|---|
| Epinephrine injection recall | Recall | Not directly retrieved — single outlet (NewsNation) citing FDA; breaking-recall exception **not met** (only 1 corroborating source, need 3+) | Matches (recall claim consistent with headline) | **Pass — confidence capped Medium.** Note: "Verify FDA.gov MedWatch/enforcement notice before publishing; seek AP/Reuters/FDA.gov corroboration." |
| Sprouts E. coli/Salmonella outbreak | Recall/outbreak | FDA.gov outbreak investigation page (direct primary source) | Matches | **Pass** — high confidence |
| Magnesium & gut health | Supplement claim | NIH ODS magnesium fact sheet (established laxative/motility mechanism) | Mild overstatement (broad "gut health" claims exceed the well-documented laxative/motility effect) | **Pass** with note: "Lead with the specific, evidence-backed mechanism, not broad microbiome claims." |
| Penn proton therapy clinical trial | Clinical trial | Penn Medicine official announcement (tier-1 institution) | Matches (trial-launch announcement only, no efficacy claims yet) | **Pass** — not applicable further; downgraded at Skill 04 (trend strength below threshold), routed to Monitor/P5 for signal reasons, not a 02b failure. |

---

## 5. Final Editorial Priority Board

```yaml
priority_board:
  - priority_level: P1
    publish_timing: immediate
    topic: "FDA recalls epinephrine injections over contamination/health risk"
    primary_entity: "FDA epinephrine injection recall"
    signal_type: recall
    allowed_category: "FDA and CDC regulatory updates"
    trend_strength_score: 62
    opportunity_score: 78
    discover_score: 4
    urgency: now
    confidence: medium
    content_status: new
    source_count: 1
    recommended_angle: "Practical safety explainer: what's recalled, why epinephrine recalls carry outsized risk (anaphylaxis is time-critical), and how this fits 2026's historic recall wave."
    why_now: "Breaking 09/04; epinephrine is the frontline treatment for anaphylaxis — a contamination recall directly affects patient safety and adds to consumer recall fatigue already documented (67% avoidance stat, Fortune)."
    primary_headline: "FDA Recalls Epinephrine Injections Over 'Potentially Fatal' Contamination Risk — What Patients Need to Know"
    next_steps: "Confirm FDA.gov MedWatch/enforcement notice and specific lots before publishing; seek AP/Reuters corroboration."
    notes: "Single-source at time of writing — confidence capped Medium per 02b. High-priority once corroborated."

  - priority_level: P2
    publish_timing: short_term
    topic: "FDA outbreak investigation: sprouts linked to E. coli and Salmonella"
    primary_entity: "Sprouts foodborne illness outbreak"
    signal_type: recall
    allowed_category: "FDA and CDC regulatory updates"
    trend_strength_score: 55
    opportunity_score: 68
    discover_score: 4
    urgency: today
    confidence: high
    content_status: new
    source_count: 1
    recommended_angle: "Explain the dual-pathogen mechanism (why sprouts are a recurring outbreak vehicle), current case status, and practical consumer guidance — distinct from prior 2026 recalls (tofu/rice/guacamole)."
    why_now: "Active FDA investigation opened 08/31; distinct product and pathogen combination not previously covered in the ongoing 2026 recall cycle."
    primary_headline: "FDA Investigates Sprouts Linked to Dual E. coli and Salmonella Outbreak"
    next_steps: "Monitor FDA page for case-count updates before finalizing; add CDC epidemiologist quote if available."
    notes: "Direct FDA primary source — strongest sourcing of today's candidates."

  - priority_level: P3
    publish_timing: scheduled
    topic: "Does magnesium actually improve gut health?"
    primary_entity: "Magnesium (gut health claims)"
    signal_type: supplement_claim
    allowed_category: "gut health and microbiome"
    trend_strength_score: 50
    opportunity_score: 72
    discover_score: 3
    urgency: this_week
    confidence: medium
    content_status: new
    source_count: 2
    recommended_angle: "Skeptical, evidence-based explainer separating magnesium citrate's documented osmotic-laxative effect from inflated 'gut health'/microbiome marketing claims — rides current rising search interest."
    why_now: "Google Trends shows 'magnesium citrate' and 'how to improve gut health' as top rising queries this week; SERP is saturated with unsubstantiated supplement content — clear differentiation gap."
    primary_headline: "Does Magnesium Really Improve Gut Health? Here's What the Science Actually Shows"
    next_steps: "Source RDN or GI specialist quote; cite NIH ODS fact sheet directly."
    notes: "Trend score sits right at minimum threshold — evergreen value justifies inclusion despite no breaking-news hook."

  - priority_level: P5
    publish_timing: monitor
    topic: "Penn launches first advanced proton therapy clinical trial"
    primary_entity: "Penn Medicine proton therapy trial"
    signal_type: clinical_trial
    allowed_category: "medical research and clinical trials"
    trend_strength_score: 43
    opportunity_score: 58
    discover_score: 2
    urgency: evergreen
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "N/A — hold pending broader pickup."
    why_now: "Single-institution announcement; no independent corroboration or patient-outcome data yet."
    primary_headline: "N/A"
    next_steps: "Re-check in 3–5 days for wire pickup (AP/Reuters/STAT) or patient-enrollment news; passed 02b (institutional source, no overstated claims) but failed trend-strength threshold."
    notes: "Deferred, not rejected — recheck_on: 2026-09-08."

summary:
  total_topics: 4
  high_priority_count: 1
  immediate_actions: "Verify FDA epinephrine recall notice and publish P1 brief same day; advance sprouts outbreak explainer within 24–48h."
```

---

## 6. Editorial Briefs — Retained Candidates

### P1 — FDA Epinephrine Injection Recall
```yaml
brief:
  primary_headline: "FDA Recalls Epinephrine Injections Over 'Potentially Fatal' Contamination Risk — What Patients Need to Know"
  alternate_headlines:
    - "Epinephrine Recall 2026: Which Lots Are Affected and What to Do If You Have One"
    - "Life-Saving Allergy Drug Recalled: What the Epinephrine Injection Alert Means for Patients"
    - "Another Major Drug Recall: Epinephrine Injections Flagged by FDA"
  topic: "FDA epinephrine injection recall"
  primary_entity: "Epinephrine injection recall"
  search_intent: "informational + practical (what to do if I have this product)"
  angle: "Safety-first explainer connecting this recall to the broader 2026 recall wave and its outsized stakes given epinephrine's emergency use."
  why_now: "Breaking today; anaphylaxis treatment delay is life-threatening, raising the safety stakes above a typical recall."
  integrity_flags:
    - "⚠️ Single-outlet sourcing (NewsNation) at time of writing — confirm against FDA.gov MedWatch/enforcement notice before publishing."
    - "⚠️ Do not name specific manufacturers/lot numbers until FDA notice is directly confirmed."
  outline:
    intro: "What was recalled and why it matters for anyone who carries emergency epinephrine."
    sections:
      - "What FDA says is wrong with the product"
      - "Who is affected and what to check"
      - "How this fits the record 2026 recall wave"
      - "What allergists recommend in the meantime"
    conclusion: "What to watch for as FDA issues further guidance."
  key_data_points:
    - "67% of American shoppers now avoid a whole food/product category after a single recall notice (Fortune, 09/02/2026)"
  source_plan:
    - { publisher: "NewsNation", url: "https://www.newsnationnow.com/us-news/recalls/epinephrine-injection-recalled-health-risks-fda/", tier: 2, used_for: "Initial recall report" }
    - { publisher: "FDA.gov", url: "[URL unverified — pending direct retrieval of enforcement notice]", tier: 1, used_for: "Primary recall confirmation" }
  evidence_requirements: "Light — recall facts + consumer safety guidance; no research claims to substantiate."
  expert_sources:
    - { type: "Board-certified allergist/immunologist", reason: "Speak to anaphylaxis risk if epinephrine access is disrupted" }
  internal_links: ["2026 FDA recall surge coverage (09-02, 09-03)"]
  visual_brief: "Product/packaging imagery once FDA notice confirms specific brand; avoid generic stock 'pills' imagery."
  seo:
    primary_keyword: "epinephrine recall 2026"
    supporting_keywords: ["epinephrine injection recall FDA", "EpiPen recall 2026", "allergy medication recall"]
    format: "News explainer"
    schema_markup: "NewsArticle"
    cluster: "2026 FDA recall surge"
  discover_notes: "Specific named drug + clear consumer question fit; capped at Discover 4 pending confirmed primary source."
  key_takeaways: ["Confirm FDA notice before publish", "Frame around patient safety urgency, not just recall mechanics"]
  estimated_word_count: "700–900"
execution_notes: "Hold for FDA.gov confirmation or second corroborating outlet before going live."
confidence: medium
```

### P2 — Sprouts E. coli/Salmonella Outbreak
```yaml
brief:
  primary_headline: "FDA Investigates Sprouts Linked to Dual E. coli and Salmonella Outbreak"
  alternate_headlines:
    - "Sprouts Outbreak: What the FDA Investigation Means for Consumers"
    - "Why Sprouts Keep Causing Foodborne Illness Outbreaks"
  topic: "Sprouts E. coli/Salmonella outbreak"
  primary_entity: "Sprouts foodborne illness outbreak"
  search_intent: "informational + practical safety guidance"
  angle: "Explain why sprouts are a recurring outbreak vehicle (warm/humid growing conditions favor pathogen growth) and give consumers clear next steps, distinguishing this from concurrent 2026 recalls."
  why_now: "FDA opened investigation 08/31/2026; distinct product/pathogen pair not covered in prior recall-surge stories."
  integrity_flags:
    - "⚠️ Case counts and full product distribution list are preliminary — avoid stating a final total."
    - "⚠️ Don't conflate E. coli (Shiga toxin) and Salmonella symptom severity — note both distinctly."
  outline:
    intro: "What FDA is investigating and why sprouts specifically"
    sections: ["The science of why raw sprouts are outbreak-prone", "Current case/product status", "How to protect yourself now", "How this fits 2026's broader recall pattern"]
    conclusion: "What updates to expect from FDA"
  key_data_points: ["FDA outbreak investigation opened 08/31/2026 — direct primary source"]
  source_plan:
    - { publisher: "FDA.gov", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-shiga-toxin-producing-e-coli-salmonella-sprouts-august-2026", tier: 1, used_for: "Primary outbreak data" }
  evidence_requirements: "Moderate — food-safety mechanism explanation + FDA data."
  expert_sources:
    - { type: "Food safety microbiologist or CDC epidemiologist", reason: "Explain sprout-specific contamination risk" }
  internal_links: ["2026 FDA recall surge coverage"]
  visual_brief: "Raw sprouts imagery with food-safety iconography; avoid implying a specific unconfirmed brand."
  seo:
    primary_keyword: "sprouts recall E. coli Salmonella"
    supporting_keywords: ["FDA sprouts outbreak 2026", "sprout food safety"]
    format: "News explainer"
    schema_markup: "NewsArticle"
    cluster: "2026 FDA recall surge"
  discover_notes: "Strong entity clarity + direct primary source; Discover 4."
  key_takeaways: ["Distinct from prior recall coverage — new pathogen/product pairing", "Direct FDA sourcing available"]
  estimated_word_count: "700–900"
execution_notes: "Update once FDA publishes case count/product list."
confidence: high
```

### P3 — Magnesium & Gut Health (concise)
```yaml
brief:
  headline: "Does Magnesium Really Improve Gut Health? Here's What the Science Actually Shows"
  topic: "Magnesium and gut health claims"
  angle: "Skeptical, evidence-first explainer distinguishing magnesium citrate's well-documented osmotic-laxative/motility effect from broader unsubstantiated 'gut health' and microbiome marketing claims, timed to rising search interest."
  key_data_points:
    - "Google Trends: 'magnesium citrate' and 'how to improve gut health' rising among top related queries this week"
  integrity_flags:
    - "⚠️ Circulating claims overstate magnesium's role in gut health broadly — lead with the specific, evidence-backed laxative/motility mechanism, not general microbiome claims."
  expert_type_needed: "Registered Dietitian Nutritionist or gastroenterologist"
  seo:
    primary_keyword: "magnesium for gut health"
    format: "Explainer/FAQ"
    serp_difficulty: "Medium"
  sources:
    - { publisher: "NIH Office of Dietary Supplements", url: "https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/" }
  estimated_word_count: "500–700"
```

---

## 7. Rejected Topics Log (selected — full list available on request)

| Topic | Reason |
|---|---|
| Medtronic Bravo CF recall, tofu recall, rice recall, guacamole recall, Baxter IV fluid recall | Existing — covered 08-28 through 09-03, no new development |
| GLP-1 psychiatric-harm study | Existing — covered 08-28 |
| LGBTQ healthcare access study | Existing — covered 08-29 |
| Ibogaine clinical trial (ASU/Barrow) | Existing — covered 09-02 |
| Wellness stacking trend | Existing — covered 08-29, no material new angle |
| September suicide prevention month | Existing — covered 09-01 |
| Cancer clinical trial access (US News opinion) | Existing/duplicate of 09-02 coverage; opinion piece adds no new data |
| Employer health costs spike 2027 (Mercer/NYT) | Off-category — pure business/insurance economics, no clinical health angle |
| OpenAI ChatGPT EHR integration; Axios "AI giants lean into health care" | Off-category — tech/business framing, no health-evidence angle |
| Screwworm/USDA livestock disease | Edge/low audience relevance — agricultural/veterinary, no established human-health angle |
| Sanford/North Memorial merger, ECU nurse awards, Luminis cyberattack, CVS/LOVB partnership, wellness-incentive law changes | Off-category — local/institutional business news |
| Penn LDI $25 incentive study, NIH/Penn State rural grant, WHO Singapore centre, UAMS/Drexel/Brown institutional announcements | Weak signal — single-institution, thin national relevance |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **Epinephrine recall**: single-source at publish time — verify FDA.gov notice before going live.
- ⚠️ **Sprouts outbreak**: case counts/product list preliminary — avoid final totals; keep E. coli and Salmonella symptom framing distinct.
- ⚠️ **Magnesium/gut health**: circulating claims overstate scope — lead with documented laxative/motility mechanism, not broad microbiome claims.

---

## 9. Run Notes

- Google Trends and Google News Radar both available and used as primary signal inputs; no tool outages.
- "FDA recall surge" is now a 6-day recurring theme (08-28 → 09-04) — today's run deliberately limited new recall coverage to genuinely distinct products/pathogens (epinephrine, sprouts) to avoid stale repetition, per staleness flag from run history review.
- site_url not configured; competitor-list fallback used for SERP-gap/duplicate context — noted on all retained candidates.
- Penn proton therapy trial deferred to `data/deferred_topics.yaml` with `recheck_on: 2026-09-08` rather than rejected outright — passed 02b cleanly but lacks independent corroboration.
- No candidates were rejected at Skill 02b this run (no unverifiable high-risk health claims or claim/source mismatches surfaced).